Physician profile
Christopher Sundstrom
NPI 1568610137
$1,178.34
in general payments reported to CMS, 2019-2025
20 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $64.13 · 2021: $204 · 2022: $26.85 · 2023: $266 · 2024: $237 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $328.89 | 2019-2025 | Aptima, Novasure, Coolseal Generator |
| Astellas Pharma US INC | $281.36 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $99.71 | 2019-2023 | Liletta |
| Coopersurgical, INC. | $57.24 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $55.23 | 2023-2025 | Myfembree |
| Ethicon US, LLC | $45.76 | 2019-2023 | Dermabond, Vistaseal |
| Medicem INC. | $39.72 | 2021 | |
| Millicent US INC | $33.87 | 2024 | Femring, Intrarosa |
| Glaxosmithkline, LLC. | $30.53 | 2019-2023 | Shingrix, Boostrix |
| Duchesnay USA Incorporated | $25.53 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.41 | 2023 | |
| Boston Scientific Corporation | $24.35 | 2025 | Axonics |
| Mayne Pharma Commercial LLC | $19.91 | 2021 | |
| Pfizer INC. | $18.94 | 2024 | |
| Organon LLC | $17.66 | 2025 | Jada System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $17.50 | 2019 | |
| Exeltis, USA INC. | $17.22 | 2023 | Slynd |
| Medtronic, INC. | $15.60 | 2021 | |
| Agile Therapeutics, INC. | $11.99 | 2021 | |
| Therapeuticsmd, INC. | $11.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sundstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.